From: Epigenetics may characterize asymptomatic COVID-19 infection
Gene | Chromosomal location (hg19) | Gene function | Hypothetical clinical implications | β-coefficient | Difference in methylation (asymptomatic – symptomatic) | Q value* |
---|---|---|---|---|---|---|
F-box only protein 16 (FBXO16) | 8.28302736 | Promotes phosphorylation-dependent ubiquination and degradation, involved in controlling amount of protein in eukaryotes | Degradation of beta-catenin leads to decreased cell adherent protein expression, leading to disruption of cardiac electrical and mechanical communication between myocytes | − 0.23 | − 0.07 | 0.004 |
Pleckstrin and Sec7 domain containing 3 (PSD3) | 8.18663702 | Codes protein, involved in endocytosis, implicated in tumor suppression | Increases signal transduction targeting proteins to subcellular compartments to respond to viral infection | − 0.14 | − 0.13 | 0.009 |
Ribonucleic acid export 1 (RAE1) | 20.55953214 | Nucleocytoplasmic transport, mitotic checkpoint regulator | This tumor suppressor gene may be important for cell division in immune cells | -0.20 | -0.11 | 0.009 |
NIPA like domain containing 2 (NIPAL2) | 8.99306708 | Autosomal recessive gene associated with congenital ichthyosis | Involved in transport of glucose and other sugars, likely in response to increased metabolic demands of infection | − 0.12 | − 0.13 | 0.019 |
SH3 and multiple ankyrin repeat domains 2 (SHANK2) | 11.70681592 | Codes postsynaptic proteins at excitatory synapses, disruption may predispose to autism or developmental delay | May play a role in SARS-CoV-2 induced altered mental status | − 0.22 | − 0.05 | 0.023 |
Phosphoglucomutase 1 (PGM1) | 1.64117325 | Codes isozyme of phosphoglucomutase (PGM), mutations cause glycogen storage disease type 14, highly polymorphic, mutations causes glycogen storage disease | Associated with breakdown and synthesis of glucose, upregulated during acute infection due to metabolic demands | − 0.15 | − 0.11 | 0.029 |